Glass House Brands (GLAS) Prepaid Assets (2020 - 2026)
Glass House Brands' (GLAS) quarterly Prepaid Assets came in at $11.2 million in Q1 2026, up 16.37% year-on-year from $9.6 million in Q1 2025, and down 28.62% on a QoQ basis from $15.7 million in Q4 2025.
Glass House Brands (GLAS) Prepaid Assets (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Prepaid Assets data on file, last reported at $11.2 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 16.37% year-over-year to $11.2 million in Q1 2026; TTM through Mar 2026 was $11.2 million, a 16.37% increase from a year earlier, with the FY2025 full-year figure at $15.7 million, up 101.47% from the prior year.
- Prepaid Assets for Q1 2026 stood at $11.2 million, down from $15.7 million in the prior quarter.
- Over the last five years, Prepaid Assets for GLAS reached as high as $20.7 million in Q3 2025 and fell as low as $3.5 million in Q1 2024.
- Historically, Prepaid Assets has averaged $8.2 million across 5 years, with a median of $7.6 million in 2022.
- Across the five-year window, Prepaid Assets sank 50.06% in 2023 and surged 251.69% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $7.8 million in 2022, then sank by 50.06% to $3.9 million in 2023, then jumped by 100.75% to $7.8 million in 2024, then soared by 101.47% to $15.7 million in 2025, then declined by 28.62% to $11.2 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $11.2 million in Q1 2026, $15.7 million in Q4 2025, and $20.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.18 Mn |
| Dec 31, 2025 | 15.66 Mn |
| Sep 30, 2025 | 20.68 Mn |
| Jun 30, 2025 | 15.36 Mn |
| Mar 31, 2025 | 9.61 Mn |
| Dec 31, 2024 | 7.78 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Jun 30, 2024 | 4.37 Mn |
| Mar 31, 2024 | 3.46 Mn |
| Dec 31, 2023 | 3.87 Mn |
| Sep 30, 2023 | 4.73 Mn |
| Jun 30, 2023 | 4.32 Mn |
| Mar 31, 2023 | 4.63 Mn |
| Dec 31, 2022 | 7.76 Mn |
| Sep 30, 2022 | 7.59 Mn |
| Jun 30, 2022 | 5.33 Mn |
| Mar 31, 2022 | 7.61 Mn |
| Dec 31, 2021 | 5.56 Mn |
| Sep 30, 2021 | 7.62 Mn |
| Jun 30, 2021 | 5.63 Mn |